Martin Shkreli Faces New Accusations Over High-Priced Drug


By BY CECILIA KANG
Business
https://ift.tt/37y7t0L
A lawsuit by the Federal Trade Commission and New York’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.
New York Times
Antitrust Laws and Competition Issues, Drugs (Pharmaceuticals), Toxoplasmosis
January 28, 2020 at 01:02AM

Popular posts from this blog

Why Do We Think It's Okay to Invade Strangers' Privacy?

Why American Spies Worry When Trump Meets Putin